1. Exploring the prominent performance of CX-4945 derivatives as protein kinase CK2 inhibitors by a combined computational study
    Xuwen Wang et al, 2014, Mol. BioSyst. CrossRef
  2. Self-Assembled Supramolecular Nanoparticles Improve the Cytotoxic Efficacy of CK2 Inhibitor THN7
    Abdelhamid Nacereddine et al, 2018, Pharmaceuticals CrossRef
  3. CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target
    Melissa Chua et al, 2017, Pharmaceuticals CrossRef
  4. Development of a high-throughput screening-compatible assay to identify inhibitors of the CK2α/CK2β interaction
    Jennifer Hochscherf et al, 2015, Analytical Biochemistry CrossRef
  5. Drug design targeting active posttranslational modification protein isoforms
    Fanwang Meng et al, 2021, Medicinal Research Reviews CrossRef
  6. Targeting the Wnt/β-catenin signaling pathway in cancer
    Ya Zhang et al, 2020, Journal of Hematology & Oncology CrossRef
  7. Identification of compounds inhibiting prion replication and toxicity by removing PrPC from the cell surface
    Silvia Biggi et al, 2020, Journal of Neurochemistry CrossRef
  8. Small molecule inhibitors of IκB kinase β: A chip-based screening and molecular docking simulation
    Yong Wan Cho et al, 2020, Bioorganic & Medicinal Chemistry CrossRef
  9. Quinalizarin, a specific CK2 inhibitor, can reduce icotinib resistance in human lung adenocarcinoma cell lines
    Ke Li et al, 2019, International Journal of Molecular Medicine CrossRef
  10. Synthesis, biological properties and structural study of new halogenated azolo[4,5-b]pyridines as inhibitors of CK2 kinase
    K. Chojnacki et al, 2021, Bioorganic Chemistry CrossRef
  11. Molecular docking of brazilin and its analogs to barrier‐to‐autointegration factor 1 (BAF1)
    Maria de Nazaré Correia Soeiro et al, 2022, Annals of the New York Academy of Sciences CrossRef
  12. Discovery of an adjuvant that resensitizes polymyxin B-resistant bacteria
    Michael Mahdavi et al, 2024, Bioorganic & Medicinal Chemistry CrossRef
  13. High-Order Perturbation Theory Models of Drug-Target Interactomes for Proteins Expressed on Networks of Hippocampus Brain Region of Alzheimer Disease Patients
    J Romero-Durán et al, 2016, Biopolymers for Medical Applications CrossRef
  14. Casein kinase: the triple meaning of a misnomer
    Andrea Venerando et al, 2014, Biochemical Journal CrossRef
  15. Quinalizarin exerts an anti-tumour effect on lung cancer A549 cells by modulating the Akt, MAPK, STAT3 and p53 signalling pathways
    Ling‑Qi Meng et al, 2017, Molecular Medicine Reports CrossRef
  16. Novel regulators of PrPC expression as potential therapeutic targets in prion diseases
    Arianna Colini Baldeschi et al, 2020, Expert Opinion on Therapeutic Targets CrossRef